The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
 
 
Employment - Inivata
Leadership - Inivata
Stock and Other Ownership Interests - Inivata
Evaluation of stored liquid biopsies for molecular profiling in patients with non-small cell lung cancer (NSCLC).
 
Penelope Ann Bradbury
Honoraria - Merck; Pfizer
 
Keyue Ding
No Relationships to Disclose
 
Peter Michael Ellis
Honoraria - Novartis; Pfizer
Consulting or Advisory Role - Pfizer
Other Relationship - Celgene; Mylan
 
Lesley Seymour
Stock and Other Ownership Interests - AstraZeneca
Consulting or Advisory Role - Boehringer Ingelheim
Research Funding - AstraZeneca (Inst); Innate Pharma (Inst); Merck (Inst); Oncolytics (Inst); Pfizer (Inst)
 
Frank De Kievit
Employment - Inivata
 
Greg Jones
Employment - Inivata; MDxHealth
Stock and Other Ownership Interests - MDxHealth
Consulting or Advisory Role - MDxHealth
 
Clive D. Morris
No Relationships to Disclose
 
Emma Green
Employment - Inivata
Stock and Other Ownership Interests - Inivata
Travel, Accommodations, Expenses - Inivata
 
Glenwood D. Goss
Honoraria - AstraZeneca; Boehringer Ingelheim; Bristol-Myers Squibb; Lilly; Pfizer
Consulting or Advisory Role - AstraZeneca; Boehringer Ingelheim; Bristol-Myers Squibb
Travel, Accommodations, Expenses - AstraZeneca; Boehringer Ingelheim; Bristol-Myers Squibb; Pfizer
 
Ming Sound Tsao
Honoraria - Bristol-Myers Squibb; Merck; Roche/Genentech; Ventana Medical Systems
Consulting or Advisory Role - AstraZeneca/MedImmune; Bristol-Myers Squibb; Merck; Pfizer; Roche
Research Funding - AstraZeneca (Inst); Merck Sharp & Dohme (Inst); Pfizer (Inst)
Patents, Royalties, Other Intellectual Property - Prognostic gene signature for early stage non-small cell lung cancer
 
Frances A. Shepherd
Stock and Other Ownership Interests - AstraZeneca; Lilly
Honoraria - AstraZeneca; Bristol-Myers Squibb; Lilly; Merck Serono; Merck Sharp & Dohme; Roche/Genentech
Consulting or Advisory Role - AstraZeneca; Boehringer Ingelheim; Lilly; Merck Serono
Research Funding - AstraZeneca/MedImmune (Inst); Bristol-Myers Squibb (Inst); Ipsen (Inst); Lilly (Inst); Merrimack (Inst); Pfizer (Inst); Roche Canada (Inst)